FHTX   $10.07  4.03% Market Open

Foghorn Therapeutics Inc.
Total Cash 285.18M
totalCashPerShare 5.154
EBITDA -91.62M
Total Debt 40.92M
quickRatio 5.606
currentRatio 5.693
Total Revenue 35.19M
debtToEquity
Revenue/Share 0.789
ROA -0.17766
ROE
grossProfits
freeCashflow -47.45M
operatingCashflow -109.63M
earningsGrowth
revenueGrowth 0.23
grossMargins -2.1174898
ebitdaMargins -2.60409
operatingMargins -3.51829
profitMargins -2.4569001
enterpriseValue 293.53M
forwardPE -6.717687
floatShares 28.82M
sharesOutstanding 55.33M
sharesShort 1.06M
sharesShortPriorMonth 1.20M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.19%
heldPercentInstitutions 0.71%
Short Ratio help_outline 8.99%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -0.259
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -86.45M
trailingEps -1.93%
forwardEps -1.47%
enterpriseToEbitda -3.20
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.44 3Q 2024
institutionsCount 105
lastUpdated Sept. 16, 2024, 8:05 p.m.